May 31, 2013
June 2 marks the 26th Annual National Cancer Survivors Day® to raise awareness of the challenges facing the nearly 14 million people who are living with a history of cancer in America. Dr. Anne Blaes leads the Cancer Survivor Program at University of Minnesota Physicians Cancer Care at Fairview, and discusses the longer-term health issues stemming from cancer and its treatment.
May 13, 2013 1:00 pm
A recent study led by researchers from the Masonic Cancer Center, University of Minnesota, found a process for mass-producing human natural killer (NK) cells, white blood cells that are known for attacking malignant tumors, to make them available for clinical-scale use.
March 8, 2013 10:49 am
One of the hardest things about fighting cancer is that drugs often hit healthy cells just as hard as the cancerous cells, causing patients to become sick from the drugs meant to help save them.
As a result researchers constantly search for new ways to increase the safety and efficacy of existing anticancer therapies. Ideally, drugs should target tumor cells while avoiding healthy cells, organs or tissue, and the drug should get to all of the cancer cells within the tumor at doses high enough to kill the cancer cells.
Recent advances in drug delivery and targeted therapies such as targeted nanoparticles have put scientists closer to achieving these goals.
February 26, 2013 1:51 pm
Masonic Cancer Center researchers identify genetic variation which may predict acute myeloid leukemia treatment success
Researchers from the College of Pharmacy and Medical School working within the Masonic Cancer Center, University of Minnesota, have partnered to identify genetic variations that may help signal which acute myeloid leukemia (AML) patients will benefit or not benefit from one of the newest antileukemic agents.
Their study is published in Clinical Cancer Research.
August 13, 2012
Chemotherapy has long been considered to be one of the most effective cancer treatments, but new research may change that view. An unexpected discovery out of the Fred Hutchinson Cancer Research Center shows chemotherapy may be causing healthy cells to promote the growth of cancer, eventually leading to treatment resistance.
The University of Minnesota's Academic Health Center's Health Talk Blog asked Douglas Yee, M.D., director of the Masonic Cancer Center about the new results and what the findings mean for cancer research here at the University of Minnesota.
July 20, 2012
Surgery is not the only option for men with prostate cancer, according to a new study from University of Minnesota professor of medicine Timothy Wilt, M.D. that looked at cases of cancer still contained to the prostate. Furthermore, Wilt found that many men who had prostate surgery to contain their cancer may not have needed it.
Wilt conducted the study in his capacity as a researcher at the Minneapolis VA Medical Center.
Wilt found that patients were still able to effectively manage their health without surgical treatment, though those with higher-risk early cancers would still see a slight benefit from surgery.
Badrinath Konety, M.D., M.B.A, chair of the University of Minnesota’s Department of Urology, believes this is an important study but that the results should be taken in stride because of a relatively low number of patients enrolled in the research.
May 17, 2012
Technology has provided a host of ways to get information into the hands of an end user. Specifically, cell phones have opened up new doors for passing along information via text message or specialized alerts.
Now, U of M researchers from the School of Social Work, Masonic Cancer Center and Department of Obstetrics, Gynecology and Women's Health will receive $675,000 over three years from the Susan G. Komen Foundation to develop new ways to use cell phones to promote breast cancer screening to Korean women.
May 2, 2012
Women who got seed radiation as part of their breast cancer treatment were more likely to have an infection or breast pain than those who were treated with whole-breast irradiation, in a new study.
And more patients treated with the quicker and more local radiation technique, also called brachytherapy, went on to need a mastectomy as well -- but there was no difference in their chance of dying in the few years after treatment.
"Many surgeons are starting to think twice about this kind of therapy for a lot of women," Dr. Todd Tuttle of Universty of Minnesota Physicians Cancer Care at Fairview told Reuters Health.